de Bartolomeis A, Ciccarelli M, De Simone G, Mazza B, Barone A, Vellucci L
Int J Mol Sci. 2023; 24(6).
PMID: 36983018
PMC: 10051989.
DOI: 10.3390/ijms24065945.
Wang Q, Ren H, Li Z, Li J, Dai L, Dong M
Eur Arch Psychiatry Clin Neurosci. 2023; 273(8):1813-1824.
PMID: 36949249
DOI: 10.1007/s00406-023-01589-8.
Nair P, McKinnon R, Miners J, Bastiampillai T
Mol Psychiatry. 2020; 25(9):1910-1919.
PMID: 32203158
DOI: 10.1038/s41380-020-0709-5.
Hassanzadah M, Bitar A, Khanfar N, Khasawneh F, Lutfy K, Shankar G
Medicine (Baltimore). 2019; 98(40):e17375.
PMID: 31577741
PMC: 6783193.
DOI: 10.1097/MD.0000000000017375.
Quigley H, MacCabe J
Ther Adv Psychopharmacol. 2019; 9:2045125319859969.
PMID: 31308936
PMC: 6604123.
DOI: 10.1177/2045125319859969.
Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia.
Whitton A, Green A, Pizzagalli D, Roth R, Williams J, Brunette M
Schizophr Bull. 2019; 45(6):1300-1308.
PMID: 30690638
PMC: 6811816.
DOI: 10.1093/schbul/sby185.
Clozapine, Diabetes Mellitus, Cardiovascular Risk and Mortality: Results of a 21-Year Naturalistic Study in Patients with Schizophrenia and Schizoaffective Disorder.
Nemani K, Greene M, Ulloa M, Vincenzi B, Copeland P, Al-Khadari S
Clin Schizophr Relat Psychoses. 2017; 12(4):168-176.
PMID: 29164928
PMC: 6489443.
DOI: 10.3371/CSRP.KNMG.111717.
The link between schizophrenia and substance use disorder: A unifying hypothesis.
Khokhar J, Dwiel L, Henricks A, Doucette W, Green A
Schizophr Res. 2017; 194:78-85.
PMID: 28416205
PMC: 6094954.
DOI: 10.1016/j.schres.2017.04.016.
An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).
Brown R, Kirby S, Denton A, Dose J, Cummins E, Drew Gill W
Schizophr Res. 2017; 194:107-114.
PMID: 28314679
PMC: 5599315.
DOI: 10.1016/j.schres.2017.03.024.
Predictors of tobacco abstinence in outpatient smokers with schizophrenia or bipolar disorder treated with varenicline and cognitive behavioral smoking cessation therapy.
Schuster R, Cather C, Pachas G, Zhang H, Cieslak K, Hoeppner S
Addict Behav. 2017; 71:89-95.
PMID: 28285208
PMC: 6499932.
DOI: 10.1016/j.addbeh.2017.02.028.
Antipsychotic Treatment and Tobacco Craving in People With Schizophrenia.
Wehring H, Heishman S, McMahon R, Liu F, Feldman S, Raley H
J Dual Diagn. 2017; 13(1):36-42.
PMID: 28166471
PMC: 5379991.
DOI: 10.1080/15504263.2017.1288946.
Smoking Use and Cessation Among People with Serious Mental Illness.
Annamalai A, Singh N, OMalley S
Yale J Biol Med. 2015; 88(3):271-7.
PMID: 26339210
PMC: 4553647.
A randomized trial of clozapine vs. other antipsychotics for cannabis use disorder in patients with schizophrenia.
Brunette M, Dawson R, OKeefe C, Narasimhan M, Noordsy D, Wojcik J
J Dual Diagn. 2015; 7(1-2):50-63.
PMID: 25914610
PMC: 4407140.
DOI: 10.1080/15504263.2011.570118.
Antipsychotic medication and tobacco use among outpatients with schizophrenia: a cross-sectional study.
Wijesundera H, Hanwella R, de Silva V
Ann Gen Psychiatry. 2014; 13(1):7.
PMID: 24642279
PMC: 3995423.
DOI: 10.1186/1744-859X-13-7.
Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans.
Lofwall M, Nuzzo P, Campbell C, Walsh S
Exp Clin Psychopharmacol. 2014; 22(3):238-47.
PMID: 24467369
PMC: 4080635.
DOI: 10.1037/a0035165.
A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia.
Karkhane Yousefi M, Folsom T, Fatemi S
J Addict Res Ther. 2012; S4(1).
PMID: 22514788
PMC: 3327361.
DOI: 10.4172/2155-6105.S4-001.
Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses.
Miwa J, Freedman R, Lester H
Neuron. 2011; 70(1):20-33.
PMID: 21482353
PMC: 4418790.
DOI: 10.1016/j.neuron.2011.03.014.
The role of antipsychotics in smoking and smoking cessation.
Matthews A, Wilson V, Mitchell S
CNS Drugs. 2011; 25(4):299-315.
PMID: 21425883
DOI: 10.2165/11588170-000000000-00000.
Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.
Montoya I, Vocci F
J Dual Diagn. 2011; 3(3-4):113-150.
PMID: 19194522
PMC: 2633934.
DOI: 10.1300/J374v03n03_09.
Smoking, Genetics and Schizophrenia: Evidence for Self Medication.
Leonard S, Mexal S, Freedman R
J Dual Diagn. 2009; 3(3-4):43-59.
PMID: 19122786
PMC: 2613326.
DOI: 10.1300/J374v03n03_05.